European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires Live01-15

European equities traded in the US as American depositary receipts are tracking higher late Wednesday morning, rising 0.44% to 1,753.15 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Grifols (GRFS) and semiconductor company Sequans Communications (SQNS), which advanced 5.2% and 5.1%, respectively. They were followed by telecommunications operator Telefonica (TEF) and petroleum refiner Equinor (EQNR), which increased 2.8% and 1.5%, respectively.

The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and 3D printer company Materialise (MTLS), which lost 4.9% and 1.3%, respectively. They were followed by internet browser company Opera (OPRA) and software firm SAP (SAP), which were down 1.1% and 1%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Mereo BioPharma Group (MREO) and software firm Endava (DAVA), which rose 9.3% and 4.8%, respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and mining company BHP Group (BHP), which were up 2.9% and 2.3%, respectively.

The decliners from the UK and Ireland were led by educational publisher Pearson (PSO) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which fell 7.8% and 4%, respectively. They were followed by biopharmaceutical company NuCana (NCNA) and biotech firm Trinity Biotech (TRIB), which dropped 3.4% and 2.1%, respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment